The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
For citations:
The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia. Pediatric pharmacology. 2023;20(5):523. (In Russ.)
Views:
456
JATS XML
Email this article 